
GWS Focused on Shanti Therapeutics Psychedelics | News Release 2023
Vancouver April 17, 2023 – Global Wellness Strategies Inc. (CSE: GWS) (Frankfurt: O3X4) (OTCQB: GWSFF) (“Global Wellness” or the “Company”) announces the Company Q3 plans
GLOBAL WELLNESS STRATEGIES
Vancouver April 17, 2023 – Global Wellness Strategies Inc. (CSE: GWS) (Frankfurt: O3X4) (OTCQB: GWSFF) (“Global Wellness” or the “Company”) announces the Company Q3 plans
Vancouver March 29, 2023 – Global Wellness Strategies Inc. (CSE: GWS) (Frankfurt: O3X4) (OTCQB: GWSFF) (“Global Wellness” or the “Company”) is pleased to announce that
Vancouver, British Columbia, February 6, 2023– Global Wellness Strategies Inc. (CSE:GWS) (Frankfurt:O3X4) (OTCQB: GWSFF) (“Global” or the “Company”) is positioned to become an MDMA and
Vancouver, British Columbia, January 31/2023: Global Wellness Strategies Inc. (CSE:GWS) (Frankfurt O3X4) (OTCQB: GWSFF) (“Global” or the “Company”) announces Shanti Therapeutics MDMA Clinical Trial Update.
Vancouver, British Columbia, December 05, 2022 – Global Wellness Strategies Inc. (CSE: GWS) (Frankfurt: O3X4) (OTCQB: GWSFF) (“Global Wellness” or the “Company”) pharma subsidiary is
Vancouver, British Columbia, November 17, 2022 – Global Wellness Strategies Inc. (CSE: GWS) (Frankfurt: O3X4) (OTCQB: GWSFF) (“Global” or the “Company”) a prospect generator that provides